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Background: Praziquantel (PZQ) is an effective pesticide against monogeneans. Its pharmacokinetics in fish may be
affected by water environment and temperature. The present study was designed to compare the pharmacokinetics,
tissue distribution, and elimination of PZQ in freshwater-acclimated grass carp and brackish water cultured grass carp.
Plasma and tissue PZQ concentrations were determined after a single 10 mg/kg oral PZQ dose.
Results: The datas of plasma and tissues drug concentration was calculated by the software SPSS 13.0. According to
the One-Way ANOVA, the results showed that the salinity had a significant effect on the drug concentration of plasma
(p < 0.01), muscle (p < 0.01), liver (p < 0.01) and kidney (p < 0.01) in the all sampling time points between the brackish
water grass carps and the freshwater grass carps, wherein, PZQ plasma and tissue concentrations in the brackish water
group were constantly lower than that in the freshwater group. The peak PZQ levels of plasma, muscle, liver, and
kidneys in the brackish water group were 0.76 μg/ml, 0.51 μg/g, 2.7 μg/g, and 2.99 μg/g, respectively; and that in the
freshwater group were 0.91 μg/ml, 0.62 μg/g, 3.87 μg/g, and 3.39 μg/g, respectively. The elimination half-lives (t1/2β) in
plasma and all tissues of the freshwater group were significantly longer than that in the brackish water group. The
elimination half-lives (t1/2β) of plasma, muscle, liver and kidneys in brackish water grass carps were 56.46, 36.17, 15.31,
and 132.64 h, respectively; and that in the freshwater grass carps were 71.15, 44.88, 23.86, and 150.23 h, respectively.
Conclusion: These findings indicate that water environment affects the tissue distribution and elimination of PZQ in
grass carps, the elimination in brackish water grass carps is more rapid than that in fresh water grass carps and tissue
concentrations of brackish water grass carps are lower than that in freshwater grass carps after orally administrating the
same dosage at the same water temperature. We speculate that the main excretion pathway of the drug is through
renal elimination, and the decreased kidney function in brackish water grass carps is likely responsible for the
considerable difference in pharmacokinetics between the two groups of grass carps.
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Praziquantel (PZQ) is widely used as a chemotherapeutic
agent for treating helminths in captive fish. It is effective
against monogeneans that infect the gills, skin, and
branchial cavities [1-13], larval and encysted digeneans
infecting the eyes [14] and skin [15], as well as intestinal
cestodes [16] of teleosts and elasmobranchs.
Grass carp (Ctenopharyngodon idellus) is an economi-
cally important species of farmed fish. In China, grass carp
has a widespread breeding distribution scope, covering
different salinity areas in the eastern and northwestern
regions, and freshwater areas of the central and southern
regions. For example, the water salinity of Lian Yungang
in Jiangsu province is 3.6‰ and that of Tachen Island in
Zhejiang province is 5.8‰ [17]. Several studies have indi-
cated that environmental water salinity can influence the
accumulation and elimination of chemicals in fish [18-22].
The difference in pharmacokinetics influences the ef-
fectiveness of PZQ in aquaculture, especially for treat-
ing monogenean infection in brackish water cultured
grass carps.
Chemical/drug pharmacokinetics in aquatic animals
can be affected by various environmental factors, such
as water temperature, PH, and salinity [23]. However,
the effect of salinity is often overlooked, especially in
freshwater fish. Moreover, in order to improve grass carp
muscle quality, the fish are often raised in brackish water
or placed into brackish water for a period of time before
listing [24]. Considering that grass carp are cultured in
both freshwater and brackish water, it is necessary to
investigate possible tissue distribution and praziquantel
elimination differences in grass carp under different
water environments. We believe that this study would
help better formulate effective PZQ regimens in treating




hexahydro-4Hpyrazino[2,1-a] isoquinoline) (99.9% pur-
ity) is used as an analytical standard and was purchased
from Sigma-Aldrich (St. Louis, MO, USA); PZQ (purity
98%) used in the pharmacokinetic study was purchased
from Feng Hua Pharmaceutical Co., Ltd., Hebei. HPLC-
grade acetonitrile was purchased from Merck (KGaA,
Germany); and all the other chemicals were of analytical
grade.
Animals
All the experiment fish precedures were reviewed and
approved by the Institutional Animal Care and Use
Committee at Shanghai Ocean University at Shanghai
Ocean University. According to the Shanghai ocean
university animal health guidelines for animal care andexperimentation. About 120 six month age Grass carps
(Ctenopharyngodon idellus, weighing 80 ± 5.6 g) were
obtained from Nantong Fisheries Farm (Yancheng, China)
and were randomly divided into two groups: freshwater
group and brackish water group and number of fish in
each group was 60. The two groups of fish were brought
in the laboratory and placed in two ponds (1 m3). The
brackish water group was gradually acclimated to brackish
water with 3.5‰ salinity for five days; circulating water
(the salinity for the freshwater and brackish water groups
were 0 and 3.5‰, respectively) and oxygen were conti-
nuously supplied using an inflation pump. Before the
experiment, the two groups were acclimated in rearing
tanks for 10 days at 22 ± 1°C. During acclimation, they
were fed twice daily with a drug-free commercial diet to
apparent satiation, then starved for 24 h before drug
administration.
Drug administration
To prepare the PZQ dosing solution, PZQ was dissolved
in 5 mL of ethanol and mixed with water to achieve a
final concentration of 2 g/L. The fish were given 5 μL/g
of the PZQ solution via gavage using a stomach tube --
with the final PZQ dosage being 10 mg/kg. After oral
drug administration, each fish was placed in an observa-
tion tank for five minutes for possible drug regurgitation;
regurgitated fish were excluded from the analysis.
Sample collection
Blood sampleswere collected from the tail sinus of five
fish at various time points (before dosing; and 0.25, 0.5,
1, 3, 6, 12, 24, 48, and 96 h after dosing); then, five fish
in each sampling time point were killed by breaking
their spine. Muscle, liver, and kidney samples were
taken, immediately frozen, and stored at −20°C until
analysis.
Sample preparation
The analytical procedure for PZQ analysis was modi-
fied according to the report of Jing Yao [25]. In brief,
the plasma (1 mL) or ground tissue samples (1 g)
were separately placed into 50-ml centrifuge tubes,
and mixed with 3 ml of ethylacetate using a Vortex
vibration meter (Thermo Fisher Scientific, USA) for
three minutes. After 10 minutes of centrifugation at
4,500 rpm, the supernatant was removed and trans-
ferred to a 15 ml centrifuge tube. The extraction step
was repeated once. The combined ethyl acetate ex-
tracts were evaporated at 45°C to dryness using the
rotary evaporation apparatus (Eppendorf, Germany).
Residues were reconstituted with 1 ml of HPLC mobile
phase, in which 2 ml of hexane was added. The mix-
ture was vortexed for three minutes and centrifuged
at 8,000 rpm for two minutes. The supernatant was
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then 20 μL was injected onto the HPLC system, as
described below.Chromatographic conditions
We used an Agilent (HP1100) HPLC system with a
fluorescence detector. The separation was performed on a
Zorbax XDB-C18 column (4.6 × 150 mm internal dia-
meter, 5-μm particle size; Agilent Technologies, USA)
using an isocratic mixture of acetonitrile: water (50:50, v/v)
as the mobile phase at a constant flow rate of 1 ml/min.
Injection volume was 20 μL, optical maser wavelength was
265 nm, emission wavelength was 280 nm, and column
temperature was 25°C.Pharmacokinetic analysis
Pharmacokinetic analysis was performed using the DAS
3.0 program; and pharmacokinetic parameters were ana-
lyzed based on the classical compartmental analysis for
plasma and tissue concentration-time data. The following
pharmacokinetic parameters were estimated: Cmax (peak
concentration), t1/2α (half-life of the absorption rate
constant), t1/2β (half-life of the elimination rate constant),
AUC(0-t) (area under the concentration-time curve from
time zero to t), and CL/F (total body clearance).Figure 1 Praziquantel in plasma and tissues of freshwater and bracki
given at vertical bars. (n = 5, The mean ± SD). (A: plasma; B: muscle; C: liverStatistical analysis
Statistical analysis between the two groups was com-
pleted using the SPSS 13.0 program.
Results
Analytical method validation
The analytical procedure for PZQ analysis was modified
according to the report of Jing Yao [25]. A linear calibra-
tion curve over the 0.05 – 20 μg/ml PZQ range was
established, yielding a correlation coefficient exceeding
0.9994. The drug concentration of the samples above the
upper calibration limit was diluted with blank plasma
and supernatants of the tissue samples. The results
showed that all inter-day and intra-day coefficients of
variation were below 3.34%; while tissue sample accuracy
ranged from 74% to 85%, and mean recovery was above
76%. Based on a signal-to-noise ratio > 3, the lower
limits of detection (LOD) and quantitation (LOQ) for
this assay were 0.05 μg⁄mL.
Pharmacokinetic analysis
The PZQ concentration-time curves are shown in Figure 1.
The pharmacokinetic parameters are shown in Table 1.
The plasma, muscle and liver of freshwater group grass
carp and the plasma, muscle and kidney of brackish
water group PZQ concentration-time profiles were bestsh water grass carps after oral administration. Standard deviation is
; D: kidney).
Table 1 Pharmacokinetic parameters of Praziquantel in grass carp (n = 5)

















Cmax ug/(g or ml) 0.91 0.76 0.62 0.51 3.87 2.70 3.39 2.99
Tmax h 0.5 0.5 0.5 1 0.5 0.5 1 1
t1/2α h 3.25 1.85 0.31 1.12 0.35 2.69 0.76 2.87
t1/2β h 71.15 56.46 44.88 36.17 23.86 15.31 150.23 132.64
t1/2Ka h 0.16 0.028 0.058 0.57 0.15 0.031 0.307 0.64
V1/F L/kg 23.57 30.15 21.53 22.22 28.38 97.33 34.30 87.17
CL/F L/h/kg 0.755 1.042 1.961 0.974 0.481 0.308 1.878 0.350
AUC(0-t) μg/L⋅h 17.951 14.614 8.096 6.865 34.984 44.047 10.411 38.663
AUC(0-∞) μg/L⋅h 26.464 19.189 10.196 20.515 41.547 64.823 10.645 57.132
K10 1/h 0.064 0.035 0.091 0.044 0.17 0.048 0.34 0.16
K12 1/h 0.235 0.212 1.574 0.474 1.469 0.113 2.034 0.754
K21 1/h 0.104 0.14 0.548 0.103 0.355 0.036 0.245 0.042
Ka 1/h 4.201 25.183 11.951 1.203 4.537 22.106 2.26 1.082
Cmax, the peak concentration in plasma; Tmax, the time point of the drug’s maximum plasma concentration; t1/2α, distribution half-life of the drug; t1/2β, elimination
half-life of the drug; t1/2Ka, absorption half-life of the drug; V1/F, extensive apparent volume of the central compartment; CL/F, total body clearance of the drug;
AUC(0-t), area under the concentration–time curve from 0 h to t; AUC(0-∞), area under the concentration–time curve from 0 h to ∞; K12, K21, first-order rate
constants for drug distribution between the central and peripheral compartments; K10, elimination rate constant from the central compartment; Ka, absorption
rate constant.
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model with first-order absorption. The kidney of fresh-
water group and liver of brackish water group PZQ
concentration-time profiles were best described by a three-
compartmental open pharmacokinetic model. The datas of
plasma and tissues drug concentration was calculated by
the software SPSS 13.0. According to the One-Way
ANOVA, the results showed that the salinity had a signifi-
cant effect on the drug concentration of plasma (p < 0.01),
musle (p < 0.01), liver (p < 0.01) and kidney (p < 0.01) in the
all sampling time points between the brackish water grass
carps and the freshwater grass carps.
PZQ distribution and elimination
Tissue concentrations are shown in Figure 1. The ab-
sorption of PZQ in freshwater grass carps was essentially
the same as the brackish water carps. There were no sig-
nificant differences in Tmax of plasma, liver, and kidneys
between the two groups.
The mean peak levels in plasma, muscle, liver and kid-
neys of the brackish water grass carps were 0.76, 0.51,
2.7, and 2.99 μg/g, respectively; which were lower than
that in the freshwater grass carps (0.91, 0.62, 3.87, and
3.39 μg/g, respectively). In most sampling time points,
the plasma and tissue PZQ levels in brackish water grass
carps were lower than that in the freshwater grass carps.
The plasma and tissue PZQ elimination half-lives
(t1/2β) in brackish water grass carps were shorter than
that in the freshwater grass carps (Table 1). The PZQelimination half-lives (t1/2β) in plasma, muscle, liver and
kidneys of the brackish water grass carps were 56.46,
36.17, 15.31, and 132.64 h, respectively; and the figures
for freshwater grass carps were 71.15, 44.88, 23.86, and
150.23 h, respectively. These findings indicated that
PZQ elimination in brackish water grass carps was more
rapid than that in freshwater grass carps.
Discussion
Monogeneans can rapidly multiply in intensive farming
facilities [26], necessitating early diagnosis, as well as
rapid and effective treatment, to prevent benign infec-
tions from becoming pathogenic. PZQ is a useful che-
motherapeutic against helminths of captive fish. There is
a need for examining factors that affect its pharmacokin-
etics in order to minimize the potential development of
anthelmintic resistance caused by extended exposure of
parasites to subcurative doses [27].
Salinity conditions play an important role in pharma-
cokinetics and fish tissue residues. For example, oxolinic
acid presents in lower concentrations for a longer period
of time in seawater teleosts than freshwater teleosts [17].
Ishida [19] reported that oxolinic acid is excreted more
slowly in freshwater trout than in seawater trout. Abedini
et al. [20] suggested that freshwater trout may be used as
a salmonid model to study oxytetracycline pharmaco-
kinetics in seawater salmon; however, drug elimination
and clearance rates in freshwater trout are remarkably
lower than that in seawater salmon. Feng et al. [21]
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tilapia are lower than that in freshwater tilapia; and the
elimination of florfenicol in seawater tilapia is more rapid
than that in freshwater tilapia. Even though grass carps
could live in both fresh and brackish waters, possible PZQ
pharmacokinetic differences between freshwater-acclimated
grass carps and brackish water grass carps have never been
reported.
In the present study, the datas of plasma and tissues
drug concentration was showed that the salinity had a
significant effect on the drug concentration of plasma
(p < 0.01), muscle (p < 0.01), liver (p < 0.01) and kidney
(p < 0.01) in the all sampling time points between the
brackish water grass carps and the freshwater grass
carps. The plasma PZQ concentration-time curve pat-
terns were similar in the two groups, which could be
best described by a two-compartmental open pharmaco-
kinetic model with first-order absorption.
The CL/F is the total body clearance of the drug and
the t1/2β is the elimination half-life of the drug. The two
pharmacokinetics parameters can describe how quickly
the drug is eliminated from the fish. The CL/F of the
freshwater group and brackish water grass carp plasma
were 0.755 and 1.042 L/h/kg respectively. The elimi-
nation half-lives (t1/2β) of plasma in freshwater water
grass carps and brackish grass carp were 71.15 and
56.46 h, respectively. Compare to the freshwater grass
carps, the brackish water grass carps have more rapidly
drug clearance and shorter elimination half-lives when
the grass carp cultured in the low salinity water. The
water salinity change will influence the regulation of os-
motic pressure in the grass carps. Even though seawater
salinity is greater than brackish water, the results indi-
cated that osmoregulation still existed in brackish water
fish, and that their drug excretion pathway may be
altered. The results were consistent with previous similar
studies [18,20,21].
K12 and K21 were the first-order rate constants for
drug distribution between the central and peripheral
compartments. The datas display that the K12 and K21
of the brackish water group grass carp were lower than
that of freshwater group in most tissues such as liver
and kidney. This phenomenon indicated that the salinity
water could decrease the drug distribution rate between
the central and peripheral compartments.
In the most sampling time points, the liver drug con-
centrations of the brackish water group are lower than
that of freshwater group which water has no salinity;
indicating that water salinity can affect drug metabolism
in the liver, and that the drug may be eliminated through
other drug excretion pathways, such as branchial excre-
tion. Sohlberg et al. [28] reported that gill excretion occurs
in seawater fish; Atlantic salmon excrete approximately
60% of administered flumequine through the gills inseawater. Feng et al. [21] reported that branchial excretion
competence in seawater fish may be attributed to active
drinking for osmoregulatory purposes of seawater tilapia;
possibly resulting to the rapid excretion of the drug and
its metabolites or their ionized complexes via the bran-
chial chloride cells.
Kidneys are the main organs that excrete drugs and its
metabolites. When the water has no salinity, the PZQ
concentration in kidney was gently rising in the previous
time points. Strangely, the PZQ concentration of brack-
ish water grass carp kidneys slowly increased between
0.25 and 0.5 h after dosing, which peaked between 0.5
and 1 h; indicating that water salinity can also affect
brackish water fish kidneys due to osmoregulation result
in kidney weakening function. For grass carps in brac-
kish water, the drug and its metabolites are likely to stay
in the body and be reabsorbed by entero-hepatic cycling
to some extent, retarding drug elimination due to the
decrease in urine output through osmoregulation. When
the renal drug concentration of brackish water grass
carps slowly increased to its peak concentration between
0.25 and 0.5 h after dosing, the drug concentrations of
the other tissues decreased. This phenomenon illustrated
that the drug in the surrounding tissues entered the kid-
neys at that time, increasing the kidney drug concen-
tration to its peak concentration; which again rapidly
declined after micturition.Conclusion
In summary, our results indicate that salinity level greatly
impacts the accumulation and tissue distribution of PZQ
in grass carps, and that its elimination in brackish water
grass carps is more rapid than that in fresh water grass
carps. Further, tissue concentrations of brackish water
grass carps are lower than that in freshwater grass carps,
after orally administrating the same dosage at the same
water temperature. We speculate that the main excretion
pathway of the drug is through renal elimination, and the
decreased kidney function in brackish water grass carps
is likely responsible for the considerable difference in
pharmacokinetics between the two groups of grass carps.
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